This paper is in the following e-collection/theme issue:

Non-Randomized Studies (funded, non-eHealth) (99) Anxiety and Stress Disorders (715) Depression and Mood Disorders; Suicide Prevention (916)

Published on in Vol 9, No 6 (2020): June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17223, first published .
The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label Study

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label Study

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label Study

Authors of this article:

Arthi Chinna Meyyappan 1, 2, 3 Author Orcid Image ;   Roumen Milev 1, 2, 3, 4 Author Orcid Image
Article Authors Cited by (2) Tweetations (8) Metrics

Journals

  1. Chinna Meyyappan A, Forth E, Wallace C, Milev R. Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review. BMC Psychiatry 2020;20(1) View
  2. Martins L, Braga Tibães J, Sanches M, Jacka F, Berk M, Teixeira A. Nutrition-based interventions for mood disorders. Expert Review of Neurotherapeutics 2021;21(3):303 View